G-H-3 International Inc. (GHTI) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 16, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerG-H-3 International Inc. (GHTI) trades at $0.00001. G-H-3 International Inc. focuses on developing products to combat aging and bodily deterioration. Sector: Healthcare.
Price as of · Last analyzed: Mar 16, 2026Analyst Coverage for GHTI: GHTI does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
G-H-3 International Inc. (GHTI) Healthcare & Pipeline Overview
G-H-3 International Inc., based in Las Vegas, develops and markets the G-H-3-Plus protocol, a combination of treatments and products aimed at anti-aging and chronic disease management. The company operates within the pharmaceuticals sector, focusing on health and vitality enhancement through its specialized protocol.
What Is the Investment Thesis for GHTI?
G-H-3 International Inc. presents a focused investment opportunity within the anti-aging and chronic disease management sector. The company's G-H-3-Plus protocol, a comprehensive and multi-faceted treatment, is the primary value driver. Growth catalysts include expanding the market reach of the G-H-3-Plus protocol and demonstrating clinical efficacy through ongoing research. Potential risks include regulatory hurdles, competition from established pharmaceutical companies, and the need for continuous innovation to maintain market relevance. Investors should closely monitor the company's ability to expand its market presence and demonstrate the long-term benefits of its G-H-3-Plus protocol.
Based on FMP financials and quantitative analysis
GHTI Key Highlights
G-H-3-Plus is a comprehensive protocol that promotes anti-aging, treats chronic disease, and improves health and vitality.
- The G-H-3-Plus protocol includes a combination of intravenous treatment, intramuscular injections, prescriptions, vitamins, and skin care products.
- The company was formerly known as The Chelsea Collection, Inc.
- G-H-3 International, Inc. is based in Las Vegas, Nevada.
- The company operates in the Medical - Pharmaceuticals industry.
Who Are GHTI's Competitors?
GHTI is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| ONC BeOne Medicines Ltd. | $358.07 | -0.20% | $38.3B | 96 5-pillar |
| DMRA Galecto, Inc. | $20.65 | +2.08% | $1.27B | 56 5-pillar |
| CGEM Cullinan Therapeutics, Inc. | $15.51 | +6.74% | $953M | 56 5-pillar |
| HITI High Tide Inc. | $2.63 | -1.50% | $231M | 38 5-pillar |
| LFMDP LifeMD, Inc. | $22.74 | -1.75% | $155M | — |
| PETS PetMed Express, Inc. | $1.36 | -0.73% | $29.1M | 32 5-pillar |
| YI 111, Inc. | $3.22 | -2.57% | $28.1M | 39 5-pillar |
| KYNB Kyntra Bio, Inc. | $6.31 | -2.92% | $25.5M | — |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are GHTI's Key Strengths?
Comprehensive G-H-3-Plus protocol.
- Focus on anti-aging and chronic disease management.
- Combination of treatments and products.
What Are GHTI's Weaknesses?
Limited market presence.
- Reliance on a single product.
- Potential regulatory hurdles.
What Are the Key Risks for GHTI?
Competition from established pharmaceutical companies and anti-aging clinics.
- Changing regulatory landscape and potential for increased scrutiny.
- Risk of product obsolescence and the need for continuous innovation.
- Limited market presence and brand recognition.
- OTC market risks, including limited liquidity and potential for price volatility.
What Are GHTI's Competitive Advantages?
- Comprehensive G-H-3-Plus protocol.
- Combination of treatments and products.
- Focus on anti-aging and chronic disease management.
What Does GHTI Do?
G-H-3 International Inc., formerly known as The Chelsea Collection, Inc., is a healthcare company dedicated to developing products that address the factors contributing to aging and bodily deterioration. Founded with the vision of enhancing health and vitality, the company is headquartered in Las Vegas, Nevada. Its flagship product, G-H-3-Plus, represents a comprehensive protocol designed to promote anti-aging, treat chronic diseases, and improve overall health. The G-H-3-Plus protocol integrates various treatment modalities, including intravenous treatments, intramuscular injections, prescriptions, vitamins, and specialized skin care products. This multi-faceted approach aims to provide a holistic solution for individuals seeking to combat the effects of aging and manage chronic health conditions. The company's focus on a comprehensive protocol distinguishes it within the pharmaceutical and anti-aging market. G-H-3 International Inc. continues to refine and market its G-H-3-Plus protocol, targeting individuals interested in proactive health management and anti-aging solutions.
What Products and Services Does GHTI Offer?
- Develops products addressing factors causing aging and deterioration.
- Offers G-H-3-Plus, a comprehensive protocol for anti-aging.
- Treats chronic diseases through the G-H-3-Plus protocol.
- Improves health and vitality with its products.
- Provides intravenous treatments as part of the protocol.
- Administers intramuscular injections.
- Offers prescription medications.
- Supplies vitamins and skin care products.
How Does GHTI Make Money?
- Develops and markets the G-H-3-Plus protocol.
- Sells a combination of treatments, prescriptions, and products.
- Generates revenue through direct sales to customers.
What Industry Does GHTI Operate In?
G-H-3 International Inc. operates within the medical pharmaceuticals industry, specifically targeting the anti-aging and chronic disease management sectors. This industry is characterized by increasing demand for innovative treatments and therapies that improve health and vitality. The competitive landscape includes established pharmaceutical companies, as well as specialized anti-aging clinics and wellness centers. G-H-3 International Inc. aims to differentiate itself through its comprehensive G-H-3-Plus protocol, offering a multi-faceted approach to address aging and chronic diseases.
Who Are GHTI's Key Customers?
- Individuals seeking anti-aging solutions.
- Patients with chronic diseases.
- People interested in improving overall health and vitality.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Company Profile
G-H-3 International Inc. operates in the Medical - Pharmaceuticals industry within the Healthcare sector. It is headquartered in Las Vegas, US. The company is led by CEO Flo Ternes. GHTI has traded publicly since 2023.
GHTI Latest News
-
Mercuria and Gunvor Profits More Than Double on War Volatility
Bloomberg · Sep 7, 2026
-
Big US university endowments outperform S&P 500 index
International homepage · Sep 7, 2026
GHTI Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for GHTI.
Price Targets
Wall Street price target analysis for GHTI.
GHTI MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for GHTI; grades run from A+ (80-100) to F (below 30).
Leadership: Flo Ternes
CEO
Flo Ternes serves as the Chief Executive Officer of G-H-3 International Inc. Further research would be required to provide a comprehensive profile.
Track Record: Due to limited information, Flo Ternes's specific achievements, strategic decisions, and company milestones under their leadership cannot be assessed. Additional data is needed to evaluate their track record at G-H-3 International Inc.
GHTI OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that G-H-3 International Inc. may not meet the minimum financial standards required for higher tiers like OTCQB or OTCQX. Companies in this tier often have limited reporting requirements and may not be subject to the same level of scrutiny as those listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries higher risks due to the potential for limited information and regulatory oversight.
- OTC Tier: OTC Other
- Limited financial disclosure.
- Potential for price manipulation.
- Higher risk of fraud.
- Lower liquidity.
- Limited regulatory oversight.
- Verify the company's financial statements.
- Research the background of the company's management team.
- Assess the company's business model and competitive landscape.
- Review the company's SEC filings (if any).
- Check for any legal or regulatory issues.
- Monitor trading volume and price volatility.
- Consult with a financial advisor.
- Company has a registered business address.
- Company has a functioning website.
- Company has a clear business model.
- CEO is known.
- Company develops products for addressing factors, which cause aging and deterioration in the body.
Common Questions About GHTI (Healthcare)
What does G-H-3 International Inc. do?
G-H-3 International Inc. develops and markets products focused on addressing the factors that cause aging and deterioration in the body.
What do analysts say about GHTI stock?
As of 2026-03-16, there is no available analyst coverage for G-H-3 International Inc. due to its OTC listing and limited market capitalization. Consequently, there are no analyst ratings, price targets, or consensus estimates for the stock.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Limited information available for G-H-3 International Inc. due to its OTC listing.
- Financial data is not readily available, making a comprehensive financial analysis challenging.
- Analyst coverage is non-existent, requiring investors to conduct their own due diligence.